SPEAKERS
Your Expert Speakers: Drug Developers, Academics & Associations







Benjamin Chen
Senior Director, Lab Head for Solid Tumor Translational Medicine Research
Bristol Myers Squibb













Deepti Aurora-Garg
Executive Director, Companion Diagnostics | Vice President Companion Diagnostics
Merck | Prometheus Biosciences

















Hilary Gee Goeckner
Senior State and Local Campaigns Manager, Access to Care
American Cancer Society Cancer Action Network


Jad Walters
Head of US IVD Development & Validation Almac Diagnostic Services
Almac Diagnostic Services

















Lakshman Ramamurthy
Head of Global Regulatory Affairs, Precision Medicine & Digital Health
GlaxoSmithKline


Lindsay Darling
Associate Director, Companion Diagnostics Portfolio Management & Operations
Regeneron








Matthew Beer
Head of NA Medical Affairs, Clinical Next-Generation Sequencing and Oncology
Thermo Fisher Scientific

















Pamela Ebrahimi
Deputy Branch Chief, Molecular Genetics Branch
CDRH, U.S. Food and Drug Administration

Partha Das
GMD Precision Medicine and Pipeline
The Janssen Pharmaceutical Companies of Johnson & Johnson





Rebecca Ann Previs
Director of Medical Affairs, Labcorp Oncology & Adjunct Faculty, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology
Duke University




Satya Saxena
Director, Global Proteomics, Clinical Pharmacology and Translational Medicine, Neurology Business Group
Eisai

Scott Bornheimer, PhD
Associate Director, Biomarkers & CDx, Medical & Scientific Affairs
BD Biosciences


Shirin Khambata Ford
Vice President, Head Companion Diagnostics, Global Companion Diagnostics, Global Oncology R&D
Daiichi Sankyo














Wen-Chi Chou
Prinical Computational Biologist, Clinical Development Predictive Sciences (Oncology)
Bristol Myers Squibb

Wenora Johnson
Research & Patient Advocate
